1 0

    FDA BLA 125504/S-063 Action Package for Cosentyx (Hidradenitis Suppurativa)

    FDA BLA 125504/S-063 Action Package for Cosentyx (Hidradenitis Suppurativa)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: Please provide the action package (alternatively referred to as the review package, review documents, or summary basis of approval) for BLA 125504/S-063 for Cosentyx (secukinumab) for the treatment of adult patients with moderate to severe hidradenitis suppurativa.
    Tags: Pharma, BLA, 2024
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details